Krithika Muthuraman
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo.
Journal: Science translational medicine
Published: May 24, 2023
Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses.
Journal: Cell reports
Published: November 09, 2022
Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells.
Journal: Antimicrobial agents and chemotherapy
Published: June 15, 2022
Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 15, 2021
Stabilized coronavirus spike stem elicits a broadly protective antibody.
Journal: Cell reports
Published: February 11, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers.
Journal: Nature communications
Published: January 13, 2021
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.
Journal: Science translational medicine
Published: October 09, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection.
Journal: bioRxiv : the preprint server for biology
Published: October 07, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026